305 related articles for article (PubMed ID: 34462843)
1. Selenium Attenuates Doxorubicin-Induced Cardiotoxicity Through Nrf2-NLRP3 Pathway.
Yang HB; Lu ZY; Yuan W; Li WD; Mao S
Biol Trace Elem Res; 2022 Jun; 200(6):2848-2856. PubMed ID: 34462843
[TBL] [Abstract][Full Text] [Related]
2. Carnosic acid protects against doxorubicin-induced cardiotoxicity through enhancing the Nrf2/HO-1 pathway.
Hu S; Liu B; Yang M; Mao S; Ju H; Liu Z; Huang M; Wu G
Food Funct; 2023 Apr; 14(8):3849-3862. PubMed ID: 37013966
[TBL] [Abstract][Full Text] [Related]
3. Trastuzumab potentiates doxorubicin-induced cardiotoxicity via activating the NLRP3 inflammasome in vivo and in vitro.
Wei S; Ma W; Yang Y; Sun T; Jiang C; Liu J; Zhang B; Li W
Biochem Pharmacol; 2023 Aug; 214():115662. PubMed ID: 37331637
[TBL] [Abstract][Full Text] [Related]
4. Natural compound glycyrrhetinic acid protects against doxorubicin-induced cardiotoxicity by activating the Nrf2/HO-1 signaling pathway.
Cheng Y; Wu X; Nie X; Wu Y; Zhang C; Lee SM; Lv K; Leung GP; Fu C; Zhang J; Li J
Phytomedicine; 2022 Nov; 106():154407. PubMed ID: 36070662
[TBL] [Abstract][Full Text] [Related]
5. Dopamine D1 receptor alleviates doxorubicin-induced cardiac injury by inhibiting NLRP3 inflammasome.
Liu J; Jin Y; Wang B; Wang Y; Zuo S; Zhang J
Biochem Biophys Res Commun; 2021 Jul; 561():7-13. PubMed ID: 33992835
[TBL] [Abstract][Full Text] [Related]
6. Involvement of ROS/NLRP3 Inflammasome Signaling Pathway in Doxorubicin-Induced Cardiotoxicity.
Wei S; Ma W; Li X; Jiang C; Sun T; Li Y; Zhang B; Li W
Cardiovasc Toxicol; 2020 Oct; 20(5):507-519. PubMed ID: 32607760
[TBL] [Abstract][Full Text] [Related]
7. Cardamonin protects against doxorubicin-induced cardiotoxicity in mice by restraining oxidative stress and inflammation associated with Nrf2 signaling.
Qi W; Boliang W; Xiaoxi T; Guoqiang F; Jianbo X; Gang W
Biomed Pharmacother; 2020 Feb; 122():109547. PubMed ID: 31918264
[TBL] [Abstract][Full Text] [Related]
8. Tanshinone I inhibits doxorubicin-induced cardiotoxicity by regulating Nrf2 signaling pathway.
Jiang Q; Chen X; Tian X; Zhang J; Xue S; Jiang Y; Liu T; Wang X; Sun Q; Hong Y; Li C; Guo D; Wang Y; Wang Q
Phytomedicine; 2022 Nov; 106():154439. PubMed ID: 36108374
[TBL] [Abstract][Full Text] [Related]
9. Dihydromyricetin alleviates doxorubicin-induced cardiotoxicity by inhibiting NLRP3 inflammasome through activation of SIRT1.
Sun Z; Lu W; Lin N; Lin H; Zhang J; Ni T; Meng L; Zhang C; Guo H
Biochem Pharmacol; 2020 May; 175():113888. PubMed ID: 32112883
[TBL] [Abstract][Full Text] [Related]
10. Bardoxolone methyl attenuates doxorubicin-induced cardiotoxicity by inhibiting the TXNIP-NLRP3 pathway through Nrf2 activation.
Zhang W; Shi C; Yao Z; Qian S
Environ Toxicol; 2024 Apr; 39(4):1936-1950. PubMed ID: 38064254
[TBL] [Abstract][Full Text] [Related]
11. Protective Effects of
Li J; Cheng Y; Li R; Wu X; Zheng C; Shiu PH; Chan JC; Rangsinth P; Liu C; Leung SW; Lee SM; Zhang C; Fu C; Zhang J; Cheung TM; Leung GP
Oxid Med Cell Longev; 2022; 2022():9266178. PubMed ID: 35693699
[TBL] [Abstract][Full Text] [Related]
12. Calycosin Alleviates Doxorubicin-Induced Cardiotoxicity and Pyroptosis by Inhibiting NLRP3 Inflammasome Activation.
Zhang L; Fan C; Jiao HC; Zhang Q; Jiang YH; Cui J; Liu Y; Jiang YH; Zhang J; Yang MQ; Li Y; Xue YT
Oxid Med Cell Longev; 2022; 2022():1733834. PubMed ID: 35035656
[TBL] [Abstract][Full Text] [Related]
13. Amentoflavone mitigates doxorubicin-induced cardiotoxicity by suppressing cardiomyocyte pyroptosis and inflammation through inhibition of the STING/NLRP3 signalling pathway.
Fang G; Li X; Yang F; Huang T; Qiu C; Peng K; Wang Z; Yang Y; Lan C
Phytomedicine; 2023 Aug; 117():154922. PubMed ID: 37321078
[TBL] [Abstract][Full Text] [Related]
14. Pinocembrin inhibited cardiomyocyte pyroptosis against doxorubicin-induced cardiac dysfunction via regulating Nrf2/Sirt3 signaling pathway.
Gu J; Huang H; Liu C; Jiang B; Li M; Liu L; Zhang S
Int Immunopharmacol; 2021 Jun; 95():107533. PubMed ID: 33752080
[TBL] [Abstract][Full Text] [Related]
15. SIRT3 attenuates doxorubicin-induced cardiotoxicity by inhibiting NLRP3 inflammasome via autophagy.
Sun Z; Fang C; Xu S; Wang B; Li D; Liu X; Mi Y; Guo H; Jiang J
Biochem Pharmacol; 2023 Jan; 207():115354. PubMed ID: 36435202
[TBL] [Abstract][Full Text] [Related]
16. Nicotinamide mononucleotide attenuates doxorubicin-induced cardiotoxicity by reducing oxidative stress, inflammation and apoptosis in rats.
Wan Y; He B; Zhu D; Wang L; Huang R; Zhu J; Wang C; Gao F
Arch Biochem Biophys; 2021 Nov; 712():109050. PubMed ID: 34610336
[TBL] [Abstract][Full Text] [Related]
17. [Honokiol reduces doxorubicin-induced cardiotoxicity
Xiong F; Liu R; Li Y; Sun N
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Aug; 42(8):1205-1211. PubMed ID: 36073220
[TBL] [Abstract][Full Text] [Related]
18. Targeting heat shock protein 47 alleviated doxorubicin-induced cardiotoxicity and remodeling in mice through suppression of the NLRP3 inflammasome.
Shi W; Chen J; Zhao N; Xing Y; Liu S; Chen M; Fang W; Zhang T; Li L; Zhang H; Zhang M; Zeng X; Chen S; Wang S; Xie S; Deng W
J Mol Cell Cardiol; 2024 Jan; 186():81-93. PubMed ID: 37995517
[TBL] [Abstract][Full Text] [Related]
19. Adiponectin agonist ADP355 ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and oxidative stress.
Zhao D; Xue C; Li J; Feng K; Zeng P; Chen Y; Duan Y; Zhang S; Li X; Han J; Yang X
Biochem Biophys Res Commun; 2020 Dec; 533(3):304-312. PubMed ID: 32958254
[TBL] [Abstract][Full Text] [Related]
20. Metformin ameliorates doxorubicin-induced cardiotoxicity targeting HMGB1/TLR4/NLRP3 signaling pathway in mice.
Alzokaky AA; Al-Karmalawy AA; Saleh MA; Abdo W; Farage AE; Belal A; Abourehab MAS; Antar SA
Life Sci; 2023 Mar; 316():121390. PubMed ID: 36649752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
